JP2022550316A5 - - Google Patents

Info

Publication number
JP2022550316A5
JP2022550316A5 JP2022518946A JP2022518946A JP2022550316A5 JP 2022550316 A5 JP2022550316 A5 JP 2022550316A5 JP 2022518946 A JP2022518946 A JP 2022518946A JP 2022518946 A JP2022518946 A JP 2022518946A JP 2022550316 A5 JP2022550316 A5 JP 2022550316A5
Authority
JP
Japan
Prior art keywords
ehd2
domain
amino acid
modified
binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022518946A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022550316A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2020/077008 external-priority patent/WO2021058804A1/en
Publication of JP2022550316A publication Critical patent/JP2022550316A/ja
Publication of JP2022550316A5 publication Critical patent/JP2022550316A5/ja
Priority to JP2025014991A priority Critical patent/JP2025081354A/ja
Pending legal-status Critical Current

Links

JP2022518946A 2019-09-25 2020-09-25 修飾ehd2ドメインを含む結合モジュール Pending JP2022550316A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025014991A JP2025081354A (ja) 2019-09-25 2025-01-31 修飾ehd2ドメインを含む結合モジュール

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19199639 2019-09-25
EP19199639.6 2019-09-25
PCT/EP2020/077008 WO2021058804A1 (en) 2019-09-25 2020-09-25 Binding modules comprising modified ehd2 domains

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025014991A Division JP2025081354A (ja) 2019-09-25 2025-01-31 修飾ehd2ドメインを含む結合モジュール

Publications (2)

Publication Number Publication Date
JP2022550316A JP2022550316A (ja) 2022-12-01
JP2022550316A5 true JP2022550316A5 (cg-RX-API-DMAC7.html) 2023-04-18

Family

ID=68109107

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022518946A Pending JP2022550316A (ja) 2019-09-25 2020-09-25 修飾ehd2ドメインを含む結合モジュール
JP2025014991A Withdrawn JP2025081354A (ja) 2019-09-25 2025-01-31 修飾ehd2ドメインを含む結合モジュール

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025014991A Withdrawn JP2025081354A (ja) 2019-09-25 2025-01-31 修飾ehd2ドメインを含む結合モジュール

Country Status (9)

Country Link
US (1) US20220372147A1 (cg-RX-API-DMAC7.html)
EP (1) EP4034244A1 (cg-RX-API-DMAC7.html)
JP (2) JP2022550316A (cg-RX-API-DMAC7.html)
KR (1) KR20220071210A (cg-RX-API-DMAC7.html)
CN (1) CN115066275A (cg-RX-API-DMAC7.html)
AU (1) AU2020356407A1 (cg-RX-API-DMAC7.html)
CA (1) CA3155725A1 (cg-RX-API-DMAC7.html)
MX (1) MX2022003507A (cg-RX-API-DMAC7.html)
WO (1) WO2021058804A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4454706A1 (en) 2023-04-24 2024-10-30 Universität Stuttgart Novel egfr binding proteins

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5731168A (en) 1995-03-01 1998-03-24 Genentech, Inc. Method for making heteromultimeric polypeptides
US7829084B2 (en) * 2001-01-17 2010-11-09 Trubion Pharmaceuticals, Inc. Binding constructs and methods for use thereof
NZ592611A (en) * 2008-10-10 2013-01-25 Emergent Product Dev Seattle A single chain fusion protein that binds to tcr complex and does not induce or induces a minimally detectable cytokine release
US20130089554A1 (en) * 2009-12-29 2013-04-11 Emergent Product Development Seattle, Llc RON Binding Constructs and Methods of Use Thereof
JP6400470B2 (ja) * 2011-05-16 2018-10-03 ジェネロン(シャンハイ)コーポレイション リミテッド 多重特異性Fab融合タンパク質および使用法
WO2013075027A2 (en) * 2011-11-17 2013-05-23 Emergent Product Development Seattle, Llc Anti-sil6xr complex binding domains and methods of use
WO2013156054A1 (en) * 2012-04-16 2013-10-24 Universität Stuttgart The igm and ige heavy chain domain 2 as covalently linked homodimerization modules for the generation of fusion proteins with dual specificity
CA3096486C (en) * 2014-11-14 2023-02-07 The Procter & Gamble Company Silicone compounds
WO2016146818A1 (en) * 2015-03-18 2016-09-22 Universität Stuttgart Single-chain tnf ligand family molecules and fusion proteins and derivatives thereof
WO2017011342A1 (en) * 2015-07-10 2017-01-19 Abbvie Inc. Igm-or-ige-modified binding proteins and uses thereof
WO2017106462A1 (en) * 2015-12-18 2017-06-22 Biogen Ma Inc. Bispecific antibody platform
HUE065861T2 (hu) * 2016-08-26 2024-06-28 Sanofi Sa Szelektív könnyûlánc-párosítást elõsegítõ multispecifikus antitestek
KR102469700B1 (ko) * 2016-09-15 2022-11-23 우니베르지테트 스튜트가르트 Her3에 대한 항원 결합 단백질
WO2019179627A1 (en) * 2018-03-22 2019-09-26 Universität Stuttgart Multivalent binding molecules
US20220396635A1 (en) * 2019-09-25 2022-12-15 Universität Stuttgart Trivalent binding molecules
HUE062777T2 (hu) * 2020-02-26 2023-12-28 Vir Biotechnology Inc SARS-CoV-2 elleni antitestek
US11192940B2 (en) * 2020-04-10 2021-12-07 Adagio Therapeutics, Inc. Compounds specific to coronavirus S protein and uses thereof
WO2022082217A1 (en) * 2020-10-16 2022-04-21 Eureka Therapeutics, Inc. Compositions for preventing or treating viral and other microbial infections

Similar Documents

Publication Publication Date Title
JP7001474B2 (ja) 非免疫原性単一ドメイン抗体
Mochly-Rosen et al. Monoclonal anti-acetylcholine-receptor antibodies directed against the cholinergic binding site
JP2020022464A5 (cg-RX-API-DMAC7.html)
JP2023504914A5 (cg-RX-API-DMAC7.html)
JP2020500510A5 (cg-RX-API-DMAC7.html)
JP6009431B2 (ja) アフィニティー精製の方法
JP2014518883A5 (cg-RX-API-DMAC7.html)
JP2024105229A5 (cg-RX-API-DMAC7.html)
DK2747782T3 (en) Long-term inhibition of interleukin-6-mediated signal transmission
CN109705213B (zh) 抗金黄色葡萄球菌毒素抗体及其用途
US20220033481A1 (en) Compositions and methods for increasing protein half-life in a serum
JP2010501552A (ja) 分配向上物質が接合された生物物質を使用した水性二相系抽出法での親和性分離方法
FR2974816A1 (fr) Methode de generation de proteines
CN105829889A (zh) 用于测定多价、多特异性分子的生物活性的基于spr的桥接测定法
CN102703388A (zh) 抗人mCRP蛋白的单克隆抗体、杂交瘤细胞系和试剂盒
JP2023553694A5 (cg-RX-API-DMAC7.html)
CN102746403A (zh) 用于elisa检测黄曲霉毒素的标准品通用替代物、其制备方法及黄曲霉毒素elisa检测方法
Reese et al. Purification of animal immunoglobulin G (IgG) using peptoid affinity ligands
CN110878124B (zh) Dna聚合酶的抗体片段、抗体及其应用
Xie et al. Outperforming biorecognition: epitope-imprinted nanoparticle enables high-species-specificity purification of human IgG
JP2024503425A5 (cg-RX-API-DMAC7.html)
Marchalonis et al. Antigenic cross-reactions among immunoglobulin of diverse vertebrates (elasmobranchs to man) detected using xenoantisera
KR20190134617A (ko) Il-1r-i 결합 폴리펩티드
CN102321177A (zh) 一种抗三聚氰胺单链抗体及其应用体
JP2004500055A5 (cg-RX-API-DMAC7.html)